CORT vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

CORT

36.3
AI Score
VS
BBIO Wins

BBIO

74.4
AI Score

Investment Advisor Scores

CORT

36score
Recommendation
AVOID NEW MONEY

BBIO

74score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CORT BBIO Winner
Forward P/E 19.305 0 Tie
PEG Ratio 0.813 0 Tie
Revenue Growth 31.7% 120.4% BBIO
Earnings Growth 24.1% 0.0% CORT
Tradestie Score 36.3/100 74.4/100 BBIO
Profit Margin 6.6% -97.0% CORT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY STRONG BUY BBIO

Relative Price Performance (Last 90 Days)

CORT 1M: -1.0% · 3M: +20.3% BBIO 1M: -2.2% · 3M: -18.3%

Current Technical Phase

CORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.6% over 20 days), RSI 51

RSI (14): 51.3 · Price: $116.28

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $67.74

Fundamentals Snapshot

Metric CORT BBIO
Market Cap — —
Forward P/E 26.4 -301.6
Trailing P/E 258.8 —
Revenue (TTM) — —
Revenue Growth 0.3% 1.2%
Gross Margin 1.0% 0.9%
Operating Margin 0.2% -0.4%
EPS 0.45 -3.54
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.